US Stock MarketDetailed Quotes

QNCX Quince Therapeutics

Watchlist
  • 0.870
  • +0.040+4.83%
Trading Jun 3 13:42 ET
37.60MMarket Cap-1144P/E (TTM)

Quince Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
22.92%8.67M
-46.98%27.14M
32.03%8.34M
-10.32%6.09M
-65.65%5.58M
-67.73%7.06M
-43.32%51.19M
-73.16%6.32M
-68.65%6.8M
-25.36%16.26M
Selling and administrative expenses
29.93%4.97M
-31.97%17.7M
38.24%4.91M
7.34%4.66M
-53.30%4.23M
-57.98%3.83M
-11.89%26.01M
-57.38%3.55M
-43.13%4.34M
28.24%9.06M
-General and administrative expense
29.93%4.97M
-31.97%17.7M
38.24%4.91M
7.34%4.66M
-53.30%4.23M
-57.98%3.83M
-11.89%26.01M
-57.38%3.55M
-43.13%4.34M
28.24%9.06M
Research and development costs
14.61%3.7M
-62.48%9.45M
24.06%3.43M
-41.62%1.43M
-81.21%1.35M
-74.68%3.23M
-58.59%25.18M
-81.81%2.77M
-82.54%2.45M
-51.09%7.2M
Operating profit
-22.92%-8.67M
46.98%-27.14M
-32.03%-8.34M
10.32%-6.09M
65.65%-5.58M
67.73%-7.06M
43.32%-51.19M
73.16%-6.32M
68.65%-6.8M
25.36%-16.26M
Net non-operating interest income expense
26.71%887K
225.66%3.48M
89.18%1.01M
204.44%959K
455.17%805K
872.22%700K
72.26%1.07M
410.48%536K
146.09%315K
-9.38%145K
Non-operating interest income
26.71%887K
225.66%3.48M
89.18%1.01M
204.44%959K
455.17%805K
872.22%700K
72.26%1.07M
410.48%536K
146.09%315K
-9.38%145K
Other net income (expense)
45.79%-3.33M
-334.58%-7.92M
-708.03%-1.51M
85.01%-216K
85.44%-107K
-4,197.33%-6.15M
-637.65%-1.82M
522.50%249K
-817.83%-1.44M
-461.07%-735K
Special income (charges)
56.86%-2.55M
-806.42%-7.48M
---1.58M
--0
--0
---5.9M
---825K
--0
---825K
--0
-Less：Restructuring and merger&acquisition
--2.55M
--1.58M
----
----
----
--0
--0
----
----
----
-Less:Impairment of capital assets
--0
615.15%5.9M
--0
--0
--0
--5.9M
--825K
--0
--825K
--0
Other non- operating income (expenses)
-219.92%-787K
55.87%-440K
-74.30%64K
64.94%-216K
85.44%-107K
-264.00%-246K
-303.64%-997K
522.50%249K
-292.36%-616K
-461.07%-735K
Income before tax
11.07%-11.12M
39.20%-31.58M
-59.79%-8.84M
32.45%-5.35M
71.00%-4.89M
42.23%-12.5M
42.25%-51.94M
76.35%-5.53M
63.51%-7.92M
22.55%-16.85M
Income tax
112.50%31K
30.63%-197K
51K
0
0
-248K
-284K
0
0
-284K
Net income
9.02%-11.15M
39.25%-31.39M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
42.56%-51.66M
76.35%-5.53M
63.51%-7.92M
23.86%-16.56M
Net income continuous Operations
9.02%-11.15M
39.25%-31.39M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
42.56%-51.66M
76.35%-5.53M
63.51%-7.92M
23.86%-16.56M
Minority interest income
Net income attributable to the parent company
9.02%-11.15M
39.25%-31.39M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
42.56%-51.66M
76.35%-5.53M
63.51%-7.92M
23.86%-16.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
9.02%-11.15M
39.25%-31.39M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
42.56%-51.66M
76.35%-5.53M
63.51%-7.92M
23.86%-16.56M
Basic earnings per share
23.53%-0.26
45.45%-0.84
-61.54%-0.21
31.82%-0.15
72.55%-0.14
52.78%-0.34
49.17%-1.54
83.33%-0.13
69.86%-0.22
31.08%-0.51
Diluted earnings per share
23.53%-0.26
45.45%-0.84
-61.54%-0.21
31.82%-0.15
72.55%-0.14
52.78%-0.34
49.17%-1.54
83.33%-0.13
69.86%-0.22
31.08%-0.51
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 22.92%8.67M-46.98%27.14M32.03%8.34M-10.32%6.09M-65.65%5.58M-67.73%7.06M-43.32%51.19M-73.16%6.32M-68.65%6.8M-25.36%16.26M
Selling and administrative expenses 29.93%4.97M-31.97%17.7M38.24%4.91M7.34%4.66M-53.30%4.23M-57.98%3.83M-11.89%26.01M-57.38%3.55M-43.13%4.34M28.24%9.06M
-General and administrative expense 29.93%4.97M-31.97%17.7M38.24%4.91M7.34%4.66M-53.30%4.23M-57.98%3.83M-11.89%26.01M-57.38%3.55M-43.13%4.34M28.24%9.06M
Research and development costs 14.61%3.7M-62.48%9.45M24.06%3.43M-41.62%1.43M-81.21%1.35M-74.68%3.23M-58.59%25.18M-81.81%2.77M-82.54%2.45M-51.09%7.2M
Operating profit -22.92%-8.67M46.98%-27.14M-32.03%-8.34M10.32%-6.09M65.65%-5.58M67.73%-7.06M43.32%-51.19M73.16%-6.32M68.65%-6.8M25.36%-16.26M
Net non-operating interest income expense 26.71%887K225.66%3.48M89.18%1.01M204.44%959K455.17%805K872.22%700K72.26%1.07M410.48%536K146.09%315K-9.38%145K
Non-operating interest income 26.71%887K225.66%3.48M89.18%1.01M204.44%959K455.17%805K872.22%700K72.26%1.07M410.48%536K146.09%315K-9.38%145K
Other net income (expense) 45.79%-3.33M-334.58%-7.92M-708.03%-1.51M85.01%-216K85.44%-107K-4,197.33%-6.15M-637.65%-1.82M522.50%249K-817.83%-1.44M-461.07%-735K
Special income (charges) 56.86%-2.55M-806.42%-7.48M---1.58M--0--0---5.9M---825K--0---825K--0
-Less：Restructuring and merger&acquisition --2.55M--1.58M--------------0--0------------
-Less:Impairment of capital assets --0615.15%5.9M--0--0--0--5.9M--825K--0--825K--0
Other non- operating income (expenses) -219.92%-787K55.87%-440K-74.30%64K64.94%-216K85.44%-107K-264.00%-246K-303.64%-997K522.50%249K-292.36%-616K-461.07%-735K
Income before tax 11.07%-11.12M39.20%-31.58M-59.79%-8.84M32.45%-5.35M71.00%-4.89M42.23%-12.5M42.25%-51.94M76.35%-5.53M63.51%-7.92M22.55%-16.85M
Income tax 112.50%31K30.63%-197K51K00-248K-284K00-284K
Net income 9.02%-11.15M39.25%-31.39M-60.72%-8.89M32.45%-5.35M70.50%-4.89M43.38%-12.25M42.56%-51.66M76.35%-5.53M63.51%-7.92M23.86%-16.56M
Net income continuous Operations 9.02%-11.15M39.25%-31.39M-60.72%-8.89M32.45%-5.35M70.50%-4.89M43.38%-12.25M42.56%-51.66M76.35%-5.53M63.51%-7.92M23.86%-16.56M
Minority interest income
Net income attributable to the parent company 9.02%-11.15M39.25%-31.39M-60.72%-8.89M32.45%-5.35M70.50%-4.89M43.38%-12.25M42.56%-51.66M76.35%-5.53M63.51%-7.92M23.86%-16.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 9.02%-11.15M39.25%-31.39M-60.72%-8.89M32.45%-5.35M70.50%-4.89M43.38%-12.25M42.56%-51.66M76.35%-5.53M63.51%-7.92M23.86%-16.56M
Basic earnings per share 23.53%-0.2645.45%-0.84-61.54%-0.2131.82%-0.1572.55%-0.1452.78%-0.3449.17%-1.5483.33%-0.1369.86%-0.2231.08%-0.51
Diluted earnings per share 23.53%-0.2645.45%-0.84-61.54%-0.2131.82%-0.1572.55%-0.1452.78%-0.3449.17%-1.5483.33%-0.1369.86%-0.2231.08%-0.51
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg